Graves' disease

New England Journal of Medicine

Volumn 358, Issue 24, 2008, Pages 2594-2605

  Brent, Gregory A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIOTHYRONINE; THYROXINE;

ADULT; APPETITE; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL ASSESSMENT; EXOPHTHALMOS; FEMALE; FOOD INTAKE; FREE THYROXINE INDEX; GRAVES DISEASE; HEART PALPITATION; HUMAN; IRRITABILITY; LOOSE FECES; PERIORBITAL EDEMA; PRIORITY JOURNAL; THYROID GLAND; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; WEIGHT REDUCTION; BLOOD; ECHOGRAPHY; HEART ARRHYTHMIA; PRACTICE GUIDELINE; PREGNANCY; REVIEW; SCINTISCANNING; THYROIDECTOMY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTITHYROID AGENTS; ARRHYTHMIAS, CARDIAC; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; THYROID GLAND; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 45149127545     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp0801880     Document Type: Article

References (55)

1. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-48.
2. Cooper DS. Hyperthyroidism. Lancet 2003;362:459-68.
3. Woeber KA. Triiodothyronine production in Graves' hyperthyroidism. Thyroid 2006;16:687-90.
4. Toft AD. Subclinical hyperthyroidism. N Engl J Med 2001;345:512-6.
5. Khoo TK, Bahn RS. Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid 2007;17:1013-8.
6. Brix TH, Kyvik KO, Christensen K, Hegedüs L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001;86:930-4.
7. Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid 2007;17:949-61.
8. Manji N, Carr-Smith JD, Boelaert K, et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 2006;91:4873-80.
9. Motomura K, Brent GA. Mechanism of thyroid hormone action: implications for the clinical manifestations of thyrotoxicosis. Endocrinol Metab Clin North Am 1998;27:1-23.
10. Brenta G, Danzi S, Klein I. Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab 2007;3:632-40.
11. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9.
12. Schwartz KM, Fatourechi V, Ahmed DDF, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002;87:438-46.
13. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005;90:6472-9.
14. Jacobsen R, Lundsgaard C, Lorenzen J, et al. Subnormal energy expenditure: a putative casual factor in the weight gain induced by treatment of hyperthyroidism. Diabetes Obes Metab 2006;8:220-7.
15. Abraham-Nordling M, Törring O, Hamberger B, et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid 2005;15:1279-86.
16. Estcourt S, Vaidya B, Quinn A, Shepherd M. The impact of thyroid eye disease upon patients' wellbeing: a qualitative analysis. Clin Endocrinol (Oxf) 2008;68:635-9.
17. Nordyke RA, Gilbert FI Jr, Harada AS. Graves' disease: influence of age on clinical findings. Arch Intern Med 1988;148:626-31.
18. Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol 2007;49:71-81.
19. Davies TF, Roti E, Braverman LE, De-Groot LJ. Thyroid controversy - stimulating antibodies. J Clin Endocrinol Metab 1998;83:3777-85.
20. Cappelli C, Pirola I, De Martino E, et al. The role of imaging in Graves' disease: a cost-effectiveness analysis. Eur J Radiol 2008;65:99-103.
21. Ota H, Amino N, Morita S, et al. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease. Clin Endocrinol (Oxf) 2007;67:41-5.
22. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R. Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metab 1998;83:2805-9.
23. Bartalena L, Baldeschi L, Dickinson AJ, et al. Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 2008;18:333-46.
24. Kahaly GJ. Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 2001;145:107-18.
25. Törring O, Tallstedt L, Wallin G, et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. J Clin Endocrinol Metab 1996;81:2986-93.
26. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17.
27. Vaidya B, Williams GR, Abraham P, Pearce SHS. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. Clin Endocrinol (Oxf) 2008;68:814-20.
28. Wartofsky L, Glinoer D, Solomon B, et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35.
29. Nakamura H, Noh JY, Itoh K, Fukata S, Myauchi A, Hamada N. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2007;92:2157-62.
30. Kubota S, Amino N, Matsumoto Y, et al. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. Thyroid 2008;18:283-7.
31. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SCL, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 2000;85:1038-42.
32. Maugendre D, Gatel A, Campion L, et al. Antithyroid drugs and Graves' disease - prospective randomized assessment of long-term treatment. Clin Endocrinol (Oxf ) 1999;50:127-32.
33. Abraham P, Avenell A, Park CM, Watson WA, Bevan JS. A systematic review of drug therapy for Graves' hyperthyroidism. Eur J Endocrinol 2005;153:489-98.
34. Weetman AP. Radioiodine treatment for benign thyroid diseases. Clin Endocrinol (Oxf) 2007;66:757-64.
35. Radioiodine in the management of benign thyroid disease: clinical guidelines: report of a working party. London: Royal College of Physicians, 2007.
36. Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radio-iodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 2007;334:514-20.
37. Walter MA, Christ-Crain M, Schindler C, Müller-Brand J, Müller B. Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison. Eur J Nucl Med Mol Imaging 2006;33:730-7.
38. Alexander EK, Larsen PR. High dose (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2002;87:1073-7.
39. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003;88:978-83.
40. Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 2005;294:71-80.
41. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 2007;92:2190-6. [Erratum, J Clin Endocrinol Metab 2007;92:4008.]
42. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998;338:73-8.
43. Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 2005;90:5321-3.
44. Ceccarelli C, Canale D, Battisti P, et al. Testicular function after 131I therapy for hyperthyroidism. Clin Endocrinol (Oxf) 2006;65:446-52.
45. Grodski S, Stalberg P, Robinson BG, Delbridge LW. Surgery versus radioiodine therapy as definitive management for Graves' disease: the role of patient preference. Thyroid 2007;17:157-60.
46. Panzer C, Beazley R, Braverman L. Rapid preoperative preparation for severe hyperthyroid Graves' disease. J Clin Endocrinol Metab 2004;89:2142-4.
47. Erbil Y, Ozluk Y, Giris M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab 2007;92:2182-9.
48. Chan GW, Mandel SJ. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 2007;3:470-8.
49. Abalovich M, Amino N, Barbour LA, al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. Clin Endocrinol Metab 2007;92:Suppl: S1-S47.
50. Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005;90:6093-8.
51. Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy: time to reconsider the mechanism? Eur J Endocrinol 2006;155:783-6.
52. Kempers MJ, van Trotsenburg AS, van Rijn RR, et al. Loss of integrity of thyroid morphology and function in children born mothers with inadequately treated Graves' disease. J Clin Endocrinol Metab 2007;92:2984-91.
53. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-12.
54. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-69.
55. Vanderpump MPJ, Ahlquist JAO, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996;313:539-44.